Autolus Therapeutics Ltd reported $-58.85M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AstraZeneca USD 4.96B 127M Jun/2025
Autolus Therapeutics Ltd USD -58.85M 4.09M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Novartis USD 5.88B 290M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Silence Therapeutics USD -22.49M 69K Jun/2025